Answers are grounded in this paper and cite their sources.
Infectious diseases and rising antibiotic resistance have intensified the search for effective antimicrobial compounds. In this study, ten chromone‐1,2,3‐triazole conjugates 8a–j were identified, and their efficacy against bacteria was evaluated employing molecular docking analysis towards the active sites of β‐ketoacyl‐ACP synthase III (KAS III) enzymes from Staphylococcus aureus (PDB ID: 4XWA) and Escherichia coli (PDB ID: 1MZS) enzyme that supports innovative structure‐based drug design strategies. Chromone‐1,2,3‐triazole conjugates 8a–d were synthesized via click chemistry using aromatic azides 7a–d , sodium ascorbate, and copper sulphate. All the newly synthesized compounds were fully characterized by 1 H‐NMR, 13 C‐NMR, and HRMS, with conjugates 8a and 8b further structurally characterized by single‐crystal x‐ray diffraction. Furthermore, SwissADME analysis revealed favourable drug‐likeness and ADMET properties, supporting their antimicrobial potential. The antimicrobial activity of the synthesized conjugates 8a , 8b , 8c , and 8d was tested. Moreover, among all the synthesized compounds, the growth inhibition ranged from 30 to 80 ppm against S . aureus (MTCC737) and from 40 to 80 ppm against E . coli (MTCC443).
No takes yet. Share an insight, caveat, or question.
Sindhumani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: